Charlotte Lozier Institute, Author at Lozier Institute

88 results

Abortion Cases in the Higher Federal Courts

Abortion advocates contend that the United States Supreme Court is on the precipice of reversing Roe v. Wade—the conservative justices are simply waiting for the arrival of another like-minded colleague, and they may find that person in Judge Amy Coney Barrett. An honest review of recent decisions by the Court, however, simply fails to support this belief. Instead of building a case for Roe’s demise, the Court has managed to make abortion jurisprudence even murkier for legislators and lower courts trying to determine the constitutionality of abortion laws, while otherwise refusing to make substantive decisions in abortion cases.

Mary E. Harned, J.D.

October 12, 2020

Please login to bookmark

COVID-19, Nursing Homes, and the Need to Protect the Elderly

In early 2020 news began circulating that a life-threatening respiratory illness was sweeping across the world and had made its way to the United States. Reactions to the severity of the problem varied, but most jurisdictions seemed underprepared to deal with how COVID-19 would impact long-term care facilities, specifically nursing homes.

Hannah Howard

October 7, 2020

Please login to bookmark

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Richard Doerflinger, M.A.

October 5, 2020

Please login to bookmark

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

Hannah Howard

October 1, 2020

Please login to bookmark

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine. This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1 It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

David Prentice, Ph.D.

September 30, 2020

Please login to bookmark

New Abortion Trends in the United States: A First Look

Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List (SBA List), published a new report on emerging abortion trends in the United States. Ahead of the Centers for Disease Control and Prevention, as well as the Guttmacher Institute, CLI has the first analysis of trends revealed by the latest available state abortion reports from calendar year 2018

Tessa Cox

September 22, 2020

Please login to bookmark

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research. First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

Tara Sander Lee, Ph.D.

James L. Sherley, M.D., Ph.D.

September 11, 2020

Please login to bookmark

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court. In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.

August 19, 2020

Please login to bookmark